S

Samuel Rivero-Hinojosa

Natera (United States)

ORCID: 0000-0002-3595-8273

58 papers and 1.3k citations.

PubIndex Score80Top 20% · early-careerHow it's scored

58Publications

1.3kTotal Citations

First publication: 2021

Top publicationsby citations

Proteogenomic discovery of neoantigens facilitates personalized multi-antigen targeted T cell immunotherapy for brain tumors

Samuel Rivero-Hinojosa, Brian R. Rood|Nature Communications|2021

Cited by 55

Indexing the rest of 58 publications…